Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis

Breast Cancer Research and Treatment

Volumn 39, Issue 1, 1996, Pages 103-117

  McLeskey, Sandra W ^a,b   Zhang, Lurong ^a   Kharbanda, Samir ^a   Kurebayashi, Junichi ^a   Lippman, Marc E ^a,b   Dickson, Robert B ^a,b   Kern, Francis G ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AGM 1470; Beta galactosidase; Fibroblast growth factors; Hormone dependence; Metastasis; Pentosan polysulfate

Indexed keywords

BETA GALACTOSIDASE; DNA; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTOR RECEPTOR; FUMAGILLOL CHLOROACETYLCARBAMATE; MESSENGER RNA; PENTOSAN POLYSULFATE; TAMOXIFEN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CELL SELECTION; CELL STRAIN MCF 7; DNA SEQUENCE; ENZYME ACTIVITY; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; OVARIECTOMY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SOUTHERN BLOTTING; TUMOR VOLUME;

ANIMALS; BREAST NEOPLASMS; CARCINOMA; CELL DIVISION; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LAC OPERON; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, FIBROBLAST GROWTH FACTOR; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029980289     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806082     Document Type: Article

References (72)

1. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324:1-8, 1991
2. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall J, Stepniewska K, Harris AL: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340:1120-1124, 1992
3. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84:1875-1887, 1992
4. Bosari S, Lee AKC, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23:755-761, 1992
5. Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris AL: Tumor angiogenesis in node-negative breast carcinoma - relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res Treat 29:109-116, 1994
6. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Palma PD, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F: Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12: 454-466, 1994
7. Folkman J, Watson K, Ingber D, Hanahan D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61, 1989
8. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D: Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66: 1095-1104, 1991
9. Li S, Shipley GD: Expression of multiple species of basic fibroblast growth factor mRNA and protein in normal and tumor-derived mammary epithelial cells in culture. Cell Growth Differ 2:195-202, 1991
10. Gomm JJ, Smith J, Ryall GK, Baillie R, Turnbull L, Coombes RC: Localization of basic fibroblast growth factor and transforming growth factor beta 1 in the human mammary gland. Cancer Res 51:4685-4692, 1991
11. Anandappa SY, Winstanley JHR, Leinster S, Green B, Rudland PS, Barraclough R: Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br J Cancer 69:772-776, 1994
12. Ke Y, Fernig DG, Wilkinson MC, Winstanley JHR, Smith JA, Rudland PS, Barraclough R: The expression of basic fibroblast growth factor and its receptor in cell lines derived from normal human mammary gland and a benign mammary lesion. J Cell Sci 106:135-143, 1993
13. Liscia DS, Merlo GR, Garrett C, French D, Mariani-Costantini R, Callahan R: Expression of int-2 mRNA in human tumors amplified at the int-2 locus. Oncogene 4:1219-1224, 1989
14. Burgess WH, Maciag T: The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58:575-606, 1989
15. Ding IYF, McLeskey SW, Chang K, Fu YM, Acol JC, Shou MT, Alitalo K, Kern FG: Expression of fibroblast growth factors (FGFs) and receptors (FGFRs) in human breast carcinomas. Proc Am Assoc Cancer Res 33:269, 1992
16. McLeskey SW, Ding IYF, Lippman ME, Kern FG: MDA-MB-134 breast carcinoma cells overexpress FGF receptors and are growth-inhibited by FGF ligands. Cancer Res 54:523-529, 1994
17. McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB, Kern FG: Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Cancer Res 53:2168-2177, 1993
18. Zhang L, Kharbanda S, Chen D, Ding IYF, Kern FG: MCF-7 breast carcinoma cells transfected with an expression vector for fibroblast growth factor 1 are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Proc Am Assoc Cancer Res 35:44, 1994
19. Wakeling AE, Dukes M, Bowler J: A potent specific pure antiestrogen with clinical potential. Cancer Res 51:3867-3873, 1991
20. Kurebayashi J, McLeskey SW, Johnson MD, Lippman ME, Dickson RB, Kern FG: Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ. Cancer Res 53: 2178-2187, 1993
21. McLeskey SW, Zhang L, Kharbanda S, Gottardis M, Trock BJ, Lippman ME, Kern FG: Tumors produced by FGF-1 or FGF-4 transfected MCF-7 breast carcinoma cells are growth-inhibited by treatment with AGM 1470 or pentosan poly sulfate. 10th Annual Meeting on Oncogenes, 368, 1994
22. Partanen J, Vainikka S, Korhonen J, Armstrong E, Alitalo K: Diverse receptors for fibroblast growth factors. Prog Growth Factor Res 4:69-83, 1992
23. Givol D, Yayon A: Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J 6:3362-3369, 1992
24. Johnson DE, Williams LT: Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 60:1-41, 1993
25. Basilico C, Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 59: 115-165, 1992
26. Hughes SE, Hall PA: Overview of the fibroblast growth factor and receptor families: complexity, functional diversity, and implications for cardiovascular research. Card Res 27:1199-1203, 1993
27. Tanaka A, Miyamoto K, Minamino N, Takeda M, Sato B, Matsuo H, Matsumoto K: Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc Natl Acad Sci USA 89:8928-8932, 1992
28. Miyamoto M, Naruo K-I, Seko C, Matsumoto S, Kondo T, Kurokawa T: Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol Cell Biol 13:4251-4259, 1993
29. Battaglia C, Berlingieri MT, Martelli ML, Trapasso F, Delli Bovi P, Fusco A: Mitogenic and dedifferentiating effect of the K-fgf/hst oncogene on rat thyroid PC clone 3 epithelial cells. Cell Growth Differ 4: 185-192, 1993
30. Levay-Young BK, Imagawa W, Wallace DR, Nandi S: Basic frbroblast growth factor stimulates the growth and inhibits casein accumulation in mouse mammary epithelial cells in vitro. Mol Cell Endocrinol 62:327-336, 1989
31. Takahashi K, Suzuki K, Kawahara S, Ono T: Growth stimulation of human breast epithelial cells by basic fibroblast growth factor in serum-free medium. Int J Cancer 43:870-874, 1989
32. Wellstein A, Lupu R, Zugmaier G, Flamm SL, Cheville AL, Delli Bovi P, Basilico C, Lippman ME, Kern FG: Autorine growth stimulation by secreted Kaposi fibroblast growth factor but not by endogenous basic fibroblast growth factor. Cell Growth Differ 1:63-71, 1990
33. Flamm SL, Wellstein A, Lupu R, Kern F, Lippman ME, Gelmann EP: Expression of fibroblast growth factor peptides in normal and malignant human mammary epithelial cells. Proc Am Assoc Cancer Res 30:71, 1989
34. Wellstein A, Zugmaier G, Califano JA III, Kern F, Paik S, Lippman ME: Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate. J Natl Cancer Inst 83:716-720, 1991
35. Fantl WJ, Johnson DE, Williams LT: Signaling by receptor tyrosine kinases. Annu Rev Biochem 62: 453-481, 1993
36. Wang J-K, Gao G, Goldfarb M: Fibroblast growth factor receptors have different signaling and mitogenic potential. Mol Cell Biol 14:181-188, 1994
37. Kan M, Huang J, Mansson P-E, Yasumitsu H, Carr B, McKeehan WL: Heparin-binding growth factor type 1 (acidic fibroblast growth factor): A potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. Proc Natl Acad Sci USA 86: 7432-7436, 1989
38. Pollock JD, Krempin M, Rudy B: Differential effects of NGF, FGF, EGF, cAMP, and dexamethasone on neunte outgrowth and sodium channel expression in PC-12 cells. J Neurosci 10:2626-2637, 1990
39. Chellaiah AT, McEwen DG, Werner S, Xu J, Ornitz DM: Fibroblast growth factor receptor 3: Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J Biol Chem 269:11620-11627, 1994
40. Vainikka S, Partanen J, Bellosta P, Coulier F, Basilico C, Jaye M, Alitalo K: Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction. EMBO J 11:4273-4280, 1992
41. Ornitz DM, Leder P: Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J Biol Chem 267:16305-16311, 1992
42. Burrus LW, Zuber ME, Lueddecke BA, Olwin BB: Identification of a cysteine-rich receptor for fibroblast growth factors. Mol Cell Biol 12:5600-5609, 1992
43. Takahashi K, Yanoma S, Ono T: Enhancement of DNA synthesis of human epithelial carcinoma cells by acidic fibroblast growth factor. Cell Struct Funct 14:121-128, 1989
44. Blood CH, Zetter BR: Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1032:89-118, 1990
45. Folkman J, Shing Y: Angiogenesis. J Biol Chem 267:10931-10934, 1992
46. Kusaka M, Sudo K, Fujita T, Marui S, Itoh F, Ingber D, Folkman J: Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun 174:1070-1076, 1991
47. Kusaka M, Sudo K, Matsutani E, Kozai Y, Marui S, Fujita T, Ingber D, Folkman J: Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br J Cancer 69:212-216, 1994
48. Yamamoto T, Sudo K, Fujita T: Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). Anticancer Res 14:1-4, 1994
49. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348:555-557, 1990
50. Yanase T, Tamura M, Fujita K, Kodama S, Tanaka K: Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res 53: 2566-2570, 1993
51. Yamaoka M, Yamamoto T, Masaki T, Ikeyama S, Sudo K, Fujita T: Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470). Cancer Res 53:4262-4267, 1993
52. Brem H, Folkman J: Analysis of experimental antiangiogenic therapy. J Ped Surg 28:445-451, 1993
53. Brem H, Gresser I, Grosfeld J, Folkman J: The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J Ped Surg 28: 1253-1257, 1993
54. Zugmaier G, Lippman ME, Wellstein A: Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals. J Natl Cancer Inst 84:1716-1724, 1992
55. Lin W-C, Pretlow TP, Pretlow TG II, Culp LA: Development of micrometastases: earliest events detected with bacterial lacZ gene-tagged tumor cells. J Natl Cancer Inst 82:1497-1503, 1990
56. Senger DR, Perruzzi CA, Feder J, Dvorak HF: A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46:5629-5632, 1986
57. Lampson LA, Wen P, Roman VA, Morris JH, Sand JA: Disseminating tumor cells and their interactions with leukocytes visualized in the brain. Cancer Res 52:1018-1025, 1992
58. Brünner N, Thompson EW, Spang-Thomsen M, Rygaard J, Dano K, Zwiebel JA: LacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis. Eur J Cancer 28A:1989-1995, 1992
59. Krüger A, Schirrmacher V, von Hoegen P: Scattered micrometastases visualized at the single-cell level: detection and re-isolation of lacZ-labeled metastasized lymphoma cells. Int J Cancer 58:275-284, 1994
60. Lin W-C, Culp LA: Altered establishment/clearance mechanisms during experimental micrometastasis with live and/or disabled bacterial lacZ-tagged tumor cells. Inv Met 12:197-209, 1992
61. Lampson LA, Lampson MA, Dunne AD: Exploiting the lacZ reporter gene for quantitative analysis of disseminated tumor growth within the brain: use of the lacZ gene product as a tumor antigen, for evaluation of antigenic modulation, and to facilitate image analysis of tumor growth in situ. Cancer Res 53: 176-182, 1993
62. Kurebayashi J, Kurosumi M, Dickson RB, Sonoo H: Angiogenesis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470) inhibits tumor angiogenesis, growth and spontaneous metastasis of MKL-4 human breast cancer cells in female athymic nude mice. Breast Cancer 1:109-115, 1994
63. Miller DL, El-Ashry D, Cheville AL, Liu Y, McLeskey SW, Kern FG: Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: Evidence for a role of EGFR in breast cancer growth and progression. Cell Growth Differ 5:1263-1274, 1994
64. Liu Y, El-Ashry D, Chen D, Ding IYF, Kern FG: MCF-7 breast cancer cells overexpressing transfected c-erbB-2 have an in vitro growth advantage in estrogen-depleted conditions and reduced estrogen dependence and tamoxifen sensitivity in vivo. Breast Cancer Res Treat 34:97-117, 1995
65. Sharfmann R, Axelrod J, Verma IM: Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc Natl Acad Sci USA 88:4626-4630, 1991
66. Schmidt EV, Christoph G, Zeller R, Leder P: The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol Cell Biol 10:4406-4411, 1990
67. Stamminger T, Fickenscher H, Fleckenstein B: Cell type-specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic AMP. J Gen Vir 71:105-113, 1990
68. Boshart M, Weber F, Jahn G, Korsch-Häsler K, Fleckenstein B, Schaffner W: A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521-530, 1985
69. Ghazal P, Lubon H, Reynolds-Kohler C, Hennighausen L, Nelson JA: Interactions between cellular regulatory proteins and a unique sequence region in the human cytomegalovirus major immediate-early promoter. Virology 174:18-20, 1990
70. Niller HH, Hennighausen L: Formation of several specific nucleoprotein complexes on the human cytomegalovirus immediate early enhancer. Nucleic Acids Res 19:3715-3721, 1991
71. Lang D, Fickenscher H, Stamminger T: Analysis of proteins binding to the proximal promoter region of the human cytomegalovirus IE-1/2 enhancer/promoter reveals both consensus and aberrant recognition sequences for transcription factors Sp1 and CREB. Nucleic Acids Res 20:3287-3295, 1992
72. Strobl JS: A role for DNA methylation in vertebrate gene expression? Mol Endocrinol 4:181-183, 1990